We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Gastroenterology

Four Typical Early Signs of Colorectal Cancer: What to Watch For

MedXY Editorial Team•Oct 2, 2025•Gastroenterology
colorectal cancerscreeningsymptoms

Overview

Colorectal cancer (cancer of the colon or rectum) is often diagnosed at a later stage, yet when detected early the five‑year survival rate can exceed 90%. In advanced stages, survival falls dramatically (around the low teens percent for stage IV). Many people miss early warning signs because everyday bowel symptoms—diarrhea, constipation, abdominal discomfort—seem common. Recognizing persistent or new changes in bowel habits and stool can lead to earlier diagnosis and better outcomes.

Four typical warning signs

Diarrhea or increased bowel frequency

A healthy bowel pattern is regular for each individual. If you suddenly have loose stools more than three times a day or a marked change from your normal pattern lasting several weeks, this may indicate inflammation or irritation in the colon. In colorectal cancer, tumor growth can ulcerate or trigger inflammation locally, which stimulates bowel motility and leads to more frequent, loose stools.

Constipation

Although opposite to diarrhea, persistent constipation can also signal a local problem in the bowel. A growing tumor may partially block the lumen, or inflammation may alter the microbial balance and bowel function. If bowel movements become much less frequent—every two to three days or even once a week—for several months, that pattern is not healthy and deserves medical evaluation.

Changes in stool shape and consistency

Normal stools are formed, cylindrical, and relatively uniform. When stools become thinner, flattened, or have sharp edges, it can reflect a mass narrowing the bowel as stool passes. A once‑cylindrical stool becoming persistently flattened is particularly suggestive of a lower rectal lesion, though this sign often appears later in disease.

Rectal bleeding or blood in stool

Fresh bright red blood on or in the stool is an important warning sign. While hemorrhoids commonly cause bright red bleeding after defecation, bleeding from colorectal cancer is often accompanied by other signs such as altered stool shape, a sensation of incomplete emptying, mucus in the stool, weight loss, or abdominal pain. Advanced disease may also cause bowel obstruction.

How to tell hemorrhoids from cancer-related bleeding

Hemorrhoidal bleeding usually appears as drops of bright red blood after stool passage and is often not accompanied by other major changes. Cancer‑related bleeding tends to be associated with additional bowel habit changes, mucus, a feeling of incomplete evacuation, or systemic symptoms such as unexplained weight loss and fatigue. Any rectal bleeding should be evaluated, especially if it is repeated or accompanied by other symptoms.

Diagnosis and treatment options

If warning signs persist, see a healthcare provider. Typical diagnostic steps include a clinical history and physical exam, fecal immunochemical test (FIT) to detect blood in stool, and colonoscopy to visualize and biopsy suspicious lesions. CT colonography and blood tests may supplement evaluation.

Treatment depends on stage. Early cancers are usually treated surgically with removal of the tumor and an appropriate segment of colon or rectum; many early cases are curable. Advanced disease may require combinations of surgery, chemotherapy (e.g., adjuvant regimens after surgery), radiotherapy for rectal tumors, and systemic targeted therapies or immunotherapy for appropriate molecular subtypes. Multidisciplinary care improves outcomes.

Prevention and screening

Screening saves lives. General guidance (varies by country) often recommends beginning routine screening around age 45 for people at average risk, earlier for those with a family history, personal history of inflammatory bowel disease, or known hereditary cancer syndromes. Screening options include colonoscopy, fecal immunochemical testing (FIT), and CT colonography. Lifestyle measures—high‑fiber diet, regular exercise, maintaining healthy weight, avoiding tobacco and limiting alcohol—also lower risk.

When to see a doctor

Seek medical advice if you notice persistent or progressive changes in bowel habits, blood in stool, unexplained weight loss, persistent abdominal pain, or a sensation of incomplete bowel emptying. Do not dismiss recurring symptoms as simply hemorrhoids without medical assessment. Early detection matters.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

New International Consensus: Colorectal Cancer Risk in MASLD — What Clinicians Need to KnowAn international Delphi panel concludes metabolic dysfunction‑associated steatotic liver disease (MASLD) raises colorectal cancer (CRC) risk. Experts call for earlier, risk‑adapted CRC screening and integrated metabolic care to reduce CRC bSep 15, 2026Germline MSH3 and MLH3 Mutations as Tumor Suppressors Elevating Colorectal Cancer Risk via Hypermutation Signature ID4Heterozygous germline mutations in MSH3 and likely MLH3 confer an increased colorectal cancer risk through somatic second hits, inducing hypermutant, microsatellite-stable tumors characterized by signature ID4 and excess somatic deletions.Sep 15, 2026New International Consensus: Screening the General Population for Islet Autoantibodies to Detect Early-Stage Type 1 DiabetesAn international expert consensus recommends practical principles and minimum requirements for general‑population screening for islet autoantibodies to detect early-stage type 1 diabetes, reduce DKA, enable early care and access to disease‑Sep 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Incidence, Survival, and Symptomatology of Recurrence in Vulvar Cancer: Insights from Population-Based Cohort Studies and Contemporary Evidence
Vulvar cancer exhibits significant recurrence rates, predominantly local, with survival declining sharply after recurrence. Awareness of recurrence-associated symptoms enhances early detection. Surgery remains pivotal in management, with fr
Sep 12, 2026
Reevaluating Colorectal Cancer Surveillance in Inflammatory Bowel Disease: The Role of Family History Beyond Early-Onset CasesA nationwide cohort study reveals that in IBD patients, colorectal cancer risk increases notably with multiple affected relatives, challenging current guidelines prioritizing early-onset family history for surveillance.Sep 6, 2026
MDADI Composite Score Thresholds for Efficient Screening of Swallowing Impairment in Head and Neck Cancer PatientsThis study validates the MD Anderson Dysphagia Inventory (MDADI) as a reliable screening tool for VFSS-graded swallowing impairment in head and neck cancer patients and proposes a concise four-item version to optimize clinical utility.Aug 27, 2026